Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro comes as a pre-filled KwikPen — the needle is already attached and cannot be swapped out by the user. Each pen delivers four weekly doses through a fixed, integrated needle, so UK patients do not need to source, fit or choose separate needles for their Mounjaro treatment. That said, questions about needle size, spare needles and safe disposal come up constantly, and the answers matter for both comfort and safety. These are prescription-only medicines; a prescriber reviews your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly designed the Mounjaro KwikPen as a sealed, self-contained injector. The needle is integrated into the pen cap assembly and activates when you press the injection button; it retracts automatically once the dose is delivered. This is not an oversight in the design, it removes a whole category of user error (fitting the wrong gauge, leaving a needle uncapped between uses, re-using a needle across doses) that is well-documented with older-generation insulin pen systems.
The practical consequence is that questions like "what needles do I need to buy for my Mounjaro pen" have a reassuring answer: none. What arrives in your delivery (in plain, unbranded packaging, tracked by DPD) is everything you need to inject. The pen handles needle attachment, depth and retraction for you. You press the button; the rest is engineered.
For anyone coming from a different injectable medication where needle selection was their responsibility, this can feel strange. The full injection technique guide walks through exactly what each step looks and feels like, which is worth reading before your first dose rather than after.
The Mounjaro SmPC, published on the electronic Medicines Compendium, confirms this integrated-needle design and specifies the injection technique, it remains the definitive reference for anyone who wants the manufacturer's exact wording on how to use the pen.
Needle depth matters because subcutaneous injections need to reach the fat layer beneath the skin without going into muscle. Research across GLP-1 and insulin delivery consistently shows that short needles (4mm to 8mm) are effective for subcutaneous administration in most adults, and shorter needles reduce injection-site pain without compromising drug absorption.
The Mounjaro KwikPen uses a short, fine-gauge integrated needle calibrated for subcutaneous delivery. Eli Lilly's clinical development programme, which included over 2,500 participants in the SURMOUNT-1 trial alone published in the New England Journal of Medicine, standardised injection technique across abdomen, thigh and upper arm sites, the three locations approved in the SmPC. Rotating between these sites weekly is recommended; repeated injection into the same small area can cause lipohypertrophy, which affects absorption.
If you have questions about needle depth relative to your body composition (particularly relevant for people with lower body fat) that is a conversation for your prescriber, not something to resolve by swapping components. The pen's depth is fixed; technique adjustments (pinching the skin, site selection) are where individual variation is managed. Our guide to Mounjaro pen needles covers the technical specifications in more detail, and if you want to understand the full range of Mounjaro injection needles that are available, we have a dedicated page walking through the options.
Because the KwikPen needle is integrated, you do not need to purchase replacement needles to use Mounjaro as prescribed. The question of spare or additional needles occasionally arises when people have used a different GLP-1 device previously (such as a pen that required individual needle attachment) and the habit carries over. For Mounjaro in the UK, it does not apply.
Sharps disposal is a different matter and genuinely important. Used Mounjaro pens cannot go into standard recycling or general household waste. UK local authorities are required to provide free sharps collection services for people injecting medicines at home, your GP practice or community pharmacy can tell you how to access the service in your area. A 1-litre sharps container is the right size for home use and keeps used pens secure between collections.
The NHS guidance on weight management injections covers disposal alongside the broader practicalities of self-injection, and is worth bookmarking as a reference once treatment starts. For anyone considering starting Mounjaro, an overview of the full tirzepatide treatment covers eligibility, how the medicine works and what to expect, a useful starting point before looking at technique detail. If you are already established on treatment and have a specific clinical question, our aftercare team is available seven days a week.
Alcohol swabs for cleaning the injection site before each dose are a standard part of good injection technique; the NHS tirzepatide medicines page gives plain-language guidance on how to prepare the skin, and if you are researching needle sizing specifically, our page on 8mm Mounjaro needles explains what that length means in practice and when it is relevant. If you are ready to take the next step, speaking to our prescribers through a free consultation is how treatment with nume begins, reviewed the same day by a named, GPhC-registered clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.